What is Art Robbins Instruments?
Art Robbins Instruments, now a key component of the Hudson Lab Automation ecosystem, serves as a critical provider of advanced laboratory automation solutions. The company specializes in the design and manufacturing of high-precision equipment, including sophisticated systems for protein crystallography, automated liquid handling, and tissue typing. By addressing the complex requirements of modern research facilities, the firm enables scientific organizations to optimize their workflows, reduce manual error, and accelerate discovery timelines. Their market position is defined by a robust portfolio of hardware that bridges the gap between traditional benchtop processes and fully integrated, high-throughput laboratory environments.
How much funding has Art Robbins Instruments raised?
Art Robbins Instruments has raised a total of $480K across 2 funding rounds:
Debt
$150K
Debt
$330K
Debt (2020): $150K with participation from PPP
Debt (2021): $330K led by PPP
Key Investors in Art Robbins Instruments
PPP
Public-Private Partnership
What's next for Art Robbins Instruments?
With the successful acquisition of this latest capital, Art Robbins Instruments is well-positioned to deepen its integration within the Hudson Lab Automation framework. The strategic focus will likely shift toward expanding the reach of their proprietary liquid handling technologies and enhancing the software-hardware synergy required for next-generation research. As the demand for automated laboratory infrastructure continues to rise, the company is expected to leverage this financial backing to capture additional market share, refine its product development lifecycle, and maintain its reputation for delivering reliable, high-performance instrumentation to the global scientific community.
See full Art Robbins Instruments company page
